LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

Search

Perrigo Co PLC

Fechado

SetorSaúde

10.66 2.21

Visão Geral

Variação de preço das ações

24h

Atual

Mín

10.35

Máximo

10.86

Indicadores-chave

By Trading Economics

Rendimento

1B

-390M

Vendas

-140M

969M

EPS

0.43

Rendimento de Dividendos

10.5

Margem de lucro

-40.229

Funcionários

8,100

EBITDA

1.4B

118M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+62.52% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

10.50%

2.38%

Próximos Ganhos

5 de ago. de 2026

Próxima data de dividendos

16 de jun. de 2026

Próxima data de ex-dividendo

28 de ago. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-79M

1.5B

Abertura anterior

8.45

Fecho anterior

10.66

Sentimento de Notícias

By Acuity

39%

61%

118 / 344 Ranking em Healthcare

Perrigo Co PLC Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

14 de jul. de 2025, 13:01 UTC

Aquisições, Fusões, Aquisições de Empresas

Perrigo to Sell Dermacosmetics Business to KKR With Focus on Streamlining Company

14 de jul. de 2025, 12:33 UTC

Aquisições, Fusões, Aquisições de Empresas

Perrigo: Business Generated About 5% of 2024 Adjusted Operating Income >PRGO

14 de jul. de 2025, 12:33 UTC

Aquisições, Fusões, Aquisições de Empresas

Perrigo: Dermacosmetics Branded Business Generated About EUR125 Million Sales in 2024 >PRGO

14 de jul. de 2025, 12:32 UTC

Aquisições, Fusões, Aquisições de Empresas

Perrigo: Deal Proceeds to Further Strengthen Balance Sheet >PRGO

14 de jul. de 2025, 12:31 UTC

Aquisições, Fusões, Aquisições de Empresas

Perrigo: Deal Includes EUR300 Million Upfront Cash, Up to EUR27 Million Contingent Payments >PRGO

14 de jul. de 2025, 12:31 UTC

Aquisições, Fusões, Aquisições de Empresas

Perrigo To Sell Dermacosmetics Branded Business to KKR Investment Vehicle >PRGO

14 de jul. de 2025, 12:30 UTC

Aquisições, Fusões, Aquisições de Empresas

Perrigo Announces Agreement to Divest Dermacosmetics Business for Up to EUR327 Million

Comparação entre Pares

Variação de preço

Perrigo Co PLC Previsão

Preço-alvo

By TipRanks

62.52% parte superior

Previsão para 12 meses

Média 17 USD  62.52%

Máximo 17 USD

Mínimo 17 USD

Com base em 2 analistas de Wall Street que oferecem metas de preço de 12 meses para Perrigo Co PLC - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

2 ratings

1

Comprar

1

Manter

0

Vender

Sentimento

By Acuity

118 / 344 Ranking em Saúde

Sentimento de Notícias

Evidência de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Perrigo Co PLC

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation, well-being, and weight management products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, Compeed Stops, XLS, Arterin, Davitamon, Apiserum, Abtei, and Nicorette brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
help-icon Live chat